Kay See Tan

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière et al. · Cancer Discovery · 2021 · 560 citations · Full text

Medicine, Oncology, Pharmacology +17

CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment

Angela DeMichele, Amy S. Clark, Kay See Tan et al. · Clinical Cancer Research · 2014 · 348 citations

Medicine, Oncology, Pharmacology +17

Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis

Takashi Eguchi, Koji Kameda, Shaohua Lu et al. · Journal of Thoracic Oncology · 2018 · 289 citations

Medicine, Oncology, Surgery +17

Trends in Critical Care Beds and Use Among Population Groups and Medicare and Medicaid Beneficiaries in the United States: 2000–2010

Neil A. Halpern, Debra A. Goldman, Kay See Tan et al. · Critical Care Medicine · 2016 · 228 citations · Full text

Medicine, Health Administration, Critical Care Medicine +14

Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non–Small-Cell Lung Cancer: A Competing Risks Analysis

Takashi Eguchi, Sarina Bains, Ming-Ching Lee et al. · Journal of Clinical Oncology · 2016 · 204 citations · Full text

Medicine, Oncology, Surgery +17